Association of Prior Authorization and Out-of-pocket Costs With Patient Access to PCSK9 Inhibitor Therapy

IMPORTANCE: Although PCSK9 inhibitors (PCSK9i) were approved in 2015, their high cost has led to strict prior authorization practices and high copays, and use of PSCK9i in clinical practice has been low. OBJECTIVE: To evaluate patient access to PCSK9i among those prescribed therapy. DESIGN, SETTING,...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:JAMA Cardiol
Main Authors: Navar, Ann Marie, Taylor, Benjamin, Mulder, Hillary, Fievitz, Eugene, Monda, Keri L., Fievitz, Anna, Maya, Juan F., López, J. Antonio G., Peterson, Eric D.
Format: Artigo
Sprog:Inglês
Udgivet: American Medical Association 2017
Fag:
Original Investigation
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5963012/
https://ncbi.nlm.nih.gov/pubmed/28973087
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamacardio.2017.3451
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker